Meeting: 130th WHO Executive Board session
Date: 16–23 January 2012
Location: Geneva, Switzerland
Provisional Agenda: http://apps.who.int/gb/ebwha/pdf_files/EB130/B130_1-en.pdf
[Editor’s Note: The provisional agenda includes a number of issues relating to global immunization and vaccines supported in part by the documents highlighted just below. We note with interest the agenda item “Draft global vaccine action plan: update EB130/21 associated with the on-going Decade of Vaccine Collaboration (DoVC) and include initial paragraphs and the closing requested action by the WHO Executive Board.
Further below we note the availability and selected items from the provisional agenda for the World Health Assembly meeting to be held in May 2012, which also includes treatment of the Global Vaccine Action Plan (GVAP).]
Monitoring of the achievement of the health-related Millennium Development Goals
Progress in the achievement of the health-related Millennium Development Goals and global health goals after 2015
Implementation of the International Health Regulations (2005)
Global mass gatherings: implications and opportunities for global health security
Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Advisory Group
Poliomyelitis: intensification of the global eradication initiative
Draft global vaccine action plan: update
Report by the Secretariat
[Initial paragraphs and closing action request; full document (6 pages) available at http://apps.who.int/gb/ebwha/pdf_files/EB130/B130_21-en.pdf ]
1. This document summarizes progress in the development of the global vaccine action plan that was initially discussed by the Sixty-fourth World Health Assembly in 2011 as part of the progress report on the implementation of the Global Immunization Vision and Strategy.1 The final version of the action plan will be presented to the Sixty-fifth World Health Assembly in May 2012.
THE GLOBAL VACCINE ACTION PLAN – AN IMMUNIZATION AGENDA FOR THE DECADE OF VACCINES
2. The Decade of Vaccines (2011–2020) envisages a world in which all individuals and communities enjoy lives that are free from vaccine-preventable diseases. Its purpose is to extend, by 2020 and beyond, the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.
3. In May 2011, the Sixty-fourth World Health Assembly noted the report on the Global Immunization Vision and Strategy 2006–2015, the first 10-year strategic framework to realize the potential of immunization in addressing morbidity and mortality from vaccine-preventable diseases. It has been a global rallying point, enabled the design of regional strategies, and guided the development of comprehensive, fully costed, multi-year national plans for immunization. The report to the Health Assembly included a description of the start of the collaborative process to develop a global vaccine action plan that builds on the success of the Global Immunization Vision and Strategy. The action plan aims to go further, integrating all aspects of immunization, including research and development, delivery, access to quality vaccines that are affordable, and public and political support. The action plan will also include projections of financial resource availability and requirements, and a clear process to define an accountability framework, arrived at through a comprehensive global, regional, and in-country consultation process…
ACTION BY THE EXECUTIVE BOARD
29. The Executive Board is invited to take note of the report and provide further guidance to support the preparation of the final draft of the global vaccine action plan.
1: Document A64/14.
Provisional Agenda for the Sixty-fifth World Health Assembly (May 2012) EB130/33: http://apps.who.int/gb/ebwha/pdf_files/EB130/B130_33-en.pdf The agenda includes the following items of special interest regarding immunization and vaccines issues:
13. Technical and health matters
13.9 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report on the work of the Advisory Group
13.10 Poliomyelitis: intensification of the global eradication initiative
13.11 Elimination of schistosomiasis
13.12 Draft global vaccine action plan
13.16 Progress reports
Disease eradication, prevention and control
D. Smallpox eradication: destruction of variola virus stocks (resolution WHA60.1)
E. Eradication of dracunculiasis (resolution WHA64.16)
F. Chagas disease: control and elimination (resolution WHA63.20)
G. Viral hepatitis (resolution WHA63.18)
H. Prevention and control of multidrug-resistant tuberculosis and extensively drug resistant tuberculosis (resolution WHA62.15)
I. Cholera: mechanisms for control and prevention (resolution WHA64.15)
J. Control of human African trypanosomiasis (resolution WHA57.2)
K. Global health sector strategy on HIV/AIDS, 2011–2015 (resolution WHA64.14)
L. Prevention and control of sexually transmitted infections: global strategy (resolution WHA59.19)